Kantas Ilias, Balatsouras Dimitrios G, Vafiadis Marinos, Apostolidou Maria Th, Pournaras Agathokles, Danielidis Vasilis
ENT Department, "G.Genimmatas" General hospital, Thessaloniki, Greece.
Eur Arch Otorhinolaryngol. 2007 Jan;264(1):9-14. doi: 10.1007/s00405-006-0145-4. Epub 2006 Oct 5.
The purpose of this study was to evaluate the effectiveness of 5% trichloroacetic acid (TCA) in the treatment of acute external otitis (AEO) in comparison with a standard clinical treatment. All patients who consecutively presented in our emergencies with AEO during the summer months of the previous year were included in the study. They were randomly divided into two groups: the study group included 117 patients treated with TCA and the control group included 98 patients treated with ear drops containing antibiotic and corticosteroid. Occasionally, an antibiotic was administered orally for 7 days, in severe cases of AEO. All patients were evaluated on days 1, 3, 5, 7 and 10, whereas another review appointment was given 20 days later. Outcome measures included evaluation of efficacy using a six-step infection score and tolerability by visual analogue scale. Additionally, adverse reactions, complications and recurrencies were recorded. Treatment was successful for all patients of the study group, whereas 8 failures were found in the control group. The infection score improved faster in the study group than in the control group, resulting in an earlier clinical cure (mean 4.1 and 8.6 days, respectively). Tolerability was significantly better in the study group, on all points of evaluation. Complications and adverse reactions were minimal on both groups. Our results show that TCA is a very effective and nontoxic agent for the treatment of AEO. Rapid pain relief and prevention of recurrencies are its main advantages.
本研究的目的是评估5%三氯乙酸(TCA)与标准临床治疗相比,在治疗急性外耳道炎(AEO)中的有效性。纳入研究的患者为上一年夏季期间连续在我院急诊就诊的AEO患者。他们被随机分为两组:研究组包括117例接受TCA治疗的患者,对照组包括98例接受含抗生素和皮质类固醇耳滴剂治疗的患者。在AEO严重的情况下,偶尔口服抗生素7天。所有患者在第1、3、5、7和10天接受评估,20天后安排另一次复诊。观察指标包括使用六步感染评分评估疗效以及通过视觉模拟量表评估耐受性。此外,记录不良反应、并发症和复发情况。研究组所有患者治疗均成功,而对照组发现8例治疗失败。研究组的感染评分改善速度比对照组快,从而实现了更早的临床治愈(分别为平均4.1天和8.6天)。在所有评估点上,研究组的耐受性明显更好。两组的并发症和不良反应均很少。我们的结果表明,TCA是治疗AEO的一种非常有效且无毒的药物。快速缓解疼痛和预防复发是其主要优点。